Growth Metrics

Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026)

Quarterly Other Non Operating Income rose 141.54% to $724061.7 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Mar 2026, up 213.18% year-over-year, with the annual reading at -$7.6 million for FY2025, 628.08% down from the prior year.

Oculis Holding AG's Other Non Operating Income history spans 5 years, with the latest figure at $724061.7 for Q1 2026.

  • Other Non Operating Income came in at $724061.7 for Q1 2026, up from $121363.5 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.5 billion in Q3 2025 to a low of -$2.2 billion in Q3 2024.
  • The 5-year median for Other Non Operating Income is -$278984.7 (2023), against an average of $17.8 million.
  • The largest YoY upside for Other Non Operating Income was 882.33% in 2024 against a maximum downside of 72670.47% in 2024.
  • Oculis Holding AG's Other Non Operating Income stood at $3.3 million in 2022, then tumbled by 174.35% to -$2.5 million in 2023, then skyrocketed by 175.75% to $1.9 million in 2024, then tumbled by 93.48% to $121363.5 in 2025, then skyrocketed by 496.61% to $724061.7 in 2026.
  • Per Business Quant, the three most recent readings for OCS's Other Non Operating Income are $724061.7 (Q1 2026), $121363.5 (Q4 2025), and $2.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 724,061.65
Dec 31, 2025 121,363.47
Sep 30, 2025 2.47 Bn
Jun 30, 2025 -5.72 Mn
Mar 31, 2025 -1.74 Mn
Dec 31, 2024 1.86 Mn
Sep 30, 2024 -2.18 Bn
Jun 30, 2024 -295,246.86
Mar 31, 2024 2.06 Mn
Dec 31, 2023 -2.46 Mn
Sep 30, 2023 -2.99 Mn
Jun 30, 2023 453,767.62
Mar 31, 2023 -262,722.51
Dec 31, 2022 3.30 Mn
Sep 30, 2022 -1.35 Mn
Jun 30, 2022 -1.46 Mn